- Home
- MD vs SANA Comparison
MD vs SANA Comparison
Compare MD & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- SANA
- Stock Information
- Founded
- MD 1979
- SANA 2018
- Country
- MD United States
- SANA United States
- Employees
- MD N/A
- SANA N/A
- Industry
- MD Hospital/Nursing Management
- SANA Medicinal Chemicals and Botanical Products
- Sector
- MD Health Care
- SANA Health Care
- Exchange
- MD Nasdaq
- SANA Nasdaq
- Market Cap
- MD 1.2B
- SANA 983.4M
- IPO Year
- MD 1995
- SANA 2021
- Fundamental
- Price
- MD $16.10
- SANA $3.17
- Analyst Decision
- MD Buy
- SANA Strong Buy
- Analyst Count
- MD 7
- SANA 5
- Target Price
- MD $16.79
- SANA $8.75
- AVG Volume (30 Days)
- MD 800.5K
- SANA 4.1M
- Earning Date
- MD 10-31-2025
- SANA 11-07-2025
- Dividend Yield
- MD N/A
- SANA N/A
- EPS Growth
- MD N/A
- SANA N/A
- EPS
- MD 1.29
- SANA N/A
- Revenue
- MD $1,940,725,000.00
- SANA N/A
- Revenue This Year
- MD N/A
- SANA N/A
- Revenue Next Year
- MD $3.09
- SANA N/A
- P/E Ratio
- MD $12.83
- SANA N/A
- Revenue Growth
- MD N/A
- SANA N/A
- 52 Week Low
- MD $10.39
- SANA $1.26
- 52 Week High
- MD $17.67
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- MD 50.53
- SANA 47.58
- Support Level
- MD $16.51
- SANA $3.07
- Resistance Level
- MD $17.06
- SANA $3.42
- Average True Range (ATR)
- MD 0.40
- SANA 0.23
- MACD
- MD -0.20
- SANA 0.04
- Stochastic Oscillator
- MD 7.95
- SANA 58.33
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.